Wei Teng

1.5k total citations
85 papers, 1.0k citations indexed

About

Wei Teng is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Wei Teng has authored 85 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hepatology, 34 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Wei Teng's work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (14 papers). Wei Teng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (14 papers). Wei Teng collaborates with scholars based in Taiwan, China and United States. Wei Teng's co-authors include Wen‐Juei Jeng, Chun‐Yen Lin, I‐Shyan Sheen, Wei‐Ting Chen, Chen‐Chun Lin, Xiaohong Dai, Xueping Yu, Shi‐Ming Lin, Lei Song and Chao Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Wei Teng

79 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Teng Taiwan 18 347 314 194 115 109 85 1.0k
Yasuhiko Sawada Japan 17 259 0.7× 308 1.0× 122 0.6× 115 1.0× 57 0.5× 79 1.1k
Ming‐Huei Chen United States 21 126 0.4× 329 1.0× 514 2.6× 26 0.2× 177 1.6× 73 1.8k
Timothy J. Maguire United States 17 224 0.6× 116 0.4× 249 1.3× 35 0.3× 54 0.5× 33 1.5k
Yewei Zhang China 20 109 0.3× 167 0.5× 626 3.2× 49 0.4× 85 0.8× 86 1.3k
Hiroyuki Kobayashi Japan 17 69 0.2× 113 0.4× 138 0.7× 29 0.3× 71 0.7× 95 1.0k
Masafumi Sakamoto Japan 14 546 1.6× 461 1.5× 40 0.2× 49 0.4× 100 0.9× 63 1.2k
Yasuo Matsuda Japan 24 334 1.0× 244 0.8× 287 1.5× 112 1.0× 36 0.3× 116 2.3k
Tonggang Liu China 16 74 0.2× 119 0.4× 164 0.8× 30 0.3× 35 0.3× 59 853
Zhenyu Ma China 23 92 0.3× 193 0.6× 594 3.1× 8 0.1× 93 0.9× 140 1.7k
Baoming Luo China 28 337 1.0× 229 0.7× 173 0.9× 9 0.1× 113 1.0× 92 2.2k

Countries citing papers authored by Wei Teng

Since Specialization
Citations

This map shows the geographic impact of Wei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Teng more than expected).

Fields of papers citing papers by Wei Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Teng. The network helps show where Wei Teng may publish in the future.

Co-authorship network of co-authors of Wei Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Teng. A scholar is included among the top collaborators of Wei Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Teng. Wei Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ou, Qianmin, Dandan Wang, Genhong Yao, et al.. (2025). Mesenchymal stromal cells induce neutrophil aggregation and extracellular vesicle storms for systemic lupus erythematosus. Signal Transduction and Targeted Therapy. 10(1). 344–344. 1 indexed citations
3.
Liang, Juyong, et al.. (2025). The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer. Cancer Cell International. 25(1). 310–310. 1 indexed citations
4.
Li, Xiaolei, Panchao Yin, Yan Wang, et al.. (2025). A Bio‐Responsive Hydrogel with Spatially Heterogeneous Structure for Treating Infectious Tissue Injuries. Advanced Science. 12(23). e2500088–e2500088. 3 indexed citations
5.
Dai, Xiaohong, et al.. (2025). The role of potential oxidative biomarkers in the prognosis of intracerebral hemorrhage and the exploration antioxidants as possible preventive and treatment options. Frontiers in Molecular Biosciences. 12. 1541230–1541230. 1 indexed citations
8.
Teng, Wei, Eric Yi-Liang Shen, Bing‐Shen Huang, et al.. (2024). Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma. The Oncologist. 29(7). e922–e931. 6 indexed citations
9.
Liu, Tsung‐Hao, San‐Chi Chen, Kun‐Ming Rau, et al.. (2024). Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression. Liver Cancer. 13(5). 509–521. 7 indexed citations
10.
Zhao, Tingting, et al.. (2024). Young small extracellular vesicles rejuvenate replicative senescence by remodeling Drp1 translocation-mediated mitochondrial dynamics. Journal of Nanobiotechnology. 22(1). 543–543. 6 indexed citations
11.
Teng, Wei, Wen‐Juei Jeng, Chen‐Chun Lin, et al.. (2024). Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment. Journal of the Formosan Medical Association. 123(7). 788–795. 2 indexed citations
12.
Li, Weichang, et al.. (2023). “one stone four birds” strategy of advanced hydrogel system based on eight-arm nanocages to promote chronic wound healing in diabetes. Chemical Engineering Journal. 475. 146174–146174. 12 indexed citations
14.
Teng, Wei, Wen‐Juei Jeng, Wei‐Ting Chen, et al.. (2022). Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma. Cancer Medicine. 12(6). 7077–7089. 17 indexed citations
15.
Li, Mingyue, Xiaohong Dai, Xueping Yu, et al.. (2021). Scalp Acupuncture Protects Against Neuronal Ferroptosis by Activating The p62-Keap1-Nrf2 Pathway in Rat Models of Intracranial Haemorrhage. Journal of Molecular Neuroscience. 72(1). 82–96. 34 indexed citations
16.
Wu, Chien‐Hsing, et al.. (2020). Efficacy and Adverse Effects of Self-Expandable Metal Stent Placement for Malignant Duodenal Obstruction: The Papilla of Vater as a Landmark. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Teng, Wei, Wen‐Juei Jeng, Chien‐Hao Huang, et al.. (2020). Postembolization fever after transarterial chemoembolization is a sign of unfavorable therapeutic response in hepatocellular carcinoma patients. Advances in digestive medicine. 7(2). 83–92. 2 indexed citations
18.
Li, Xiting, et al.. (2018). Quantitative Evaluation of MMP-9 and TIMP-1 Promoter Methylation in Chronic Periodontitis. DNA and Cell Biology. 37(3). 168–173. 17 indexed citations
19.
Zou, Wei, Xiaohong Dai, Xueping Yu, et al.. (2018). Baihui (DU20)-penetrating-Qubin (GB7) acupuncture inhibits apoptosis in the perihemorrhagic penumbra. Neural Regeneration Research. 13(9). 1602–1602. 16 indexed citations
20.
Zou, Wei, Xueping Yu, Xiaoying Liu, et al.. (2018). Acupuncture through Baihui (DU20) to Qubin (GB7) mitigates neurological impairment after intracerebral hemorrhage. Neural Regeneration Research. 13(8). 1425–1425. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026